´Ù¾çÇÑ Ä¡¸Å Ä¡·á Ȱ¾à ´º¿åŸÀÓÁîµµ ÁÖ¸ñ
| Á¦ ¸ñ | Ä¡¸ÅÀÇ ½Å°æÇൿÁõ»ó |
|---|---|
| ÃâÆÇ»ç | ´ëÇÑÀÇÇÐ |
| ¹ßÇàÀÏ | 2017 |
| Á¦ ¸ñ | Amyloid PET Neuroimaging |
|---|---|
| ÃâÆÇ»ç | ¸ÞµðÄ®¾÷Àú¹ö |
| ¹ßÇàÀÏ | 2017 |
| Á¦ ¸ñ | Memantine from basic research to Clinical Practice-2nd editioin |
|---|---|
| ÃâÆÇ»ç | ¸ÞµðÄ®¾÷Àú¹ö |
| ¹ßÇàÀÏ | 2015 |
| Á¦ ¸ñ | ½Å°æ¡¤Á¤½ÅÀÇÇÐÀÇ ³ú°úÇÐ |
|---|---|
| ÃâÆÇ»ç | ±ºÀÚÃâÆÇ»ç |
| ¹ßÇàÀÏ | 2013 |
| Á¦ ¸ñ | Memantine from basic research to clinical practice -1st edition |
|---|---|
| ÃâÆÇ»ç | ¸ÞµðÄ®¾÷Àú¹ö |
| ¹ßÇàÀÏ | 2013 |
| Á¦ ¸ñ | Clinical Significance of Physical Frailty in Subjects With Subjective Cognitive Decline: A Prospective Study With Amyloid PET Data |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | JOURNAL OF CLINICAL NEUROLOGY |
| Á¦ ¸ñ | Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | ALZHEIMERS RESEARCH & THERAPY |
| Á¦ ¸ñ | A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa?? Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD) |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | NEUROLOGY AND THERAPY |
| Á¦ ¸ñ | PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer's disease |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | SCIENTIFIC REPORTS |
| Á¦ ¸ñ | Development of a home-based cognitive test for cognitive monitoring in subjective cognitive decline with high risk of Alzheimer's disease |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | MEDICINE |

°¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº 1980³â °³² Áö¿ª ÃÖÃÊÀÇ Á¾ÇÕº´¿øÀ¸·Î ¼¼¿öÁ³´Ù. ÇöÀç Áö»ó 22Ãþ, ÁöÇÏ 6ÃþÀÇ 1355º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖÀ¸¸ç ´ÜÀÏ °Ç¹° º´¿øÀ¸·Î´Â ±¹³» ÃÖ´ë ±Ô¸ðÀÌ´Ù. °¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº °¡Å縯±³È¸ÀÇ ´ëÇ¥ º´¿øÀ¸·Î °¡Å縯Áß¾ÓÀÇ·á¿øÀÇ ÀÌ³ä ½Çõ¿¡ Àû±Ø ¾ÕÀå¼°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ ¸ÕÀú »ý°¢ÇÏ´Â Àü¹®¼¾ÅÍ Áß½ÉÀÇ º´¿ø, 21¼¼±â ÃÖ÷´Ü ÀÇ·á ½Ã½ºÅÛ º´¿øÀ¸·Î °Åµì³ª°í ÀÖ´Ù.
¼¿ïƯº°½Ã ¼Ãʱ¸ ¹ÝÆ÷´ë·Î 222